Blog & Events

In honor of International Clinical Trials Day - a day dedicated to celebrating the vital contributions of clinical research professionals and organizations around the world - we sat down with our CRO’s CEO, Aurélie Weiss-Guimet, a clinical research professional with…

In an ideal clinical trial, investigational treatments run seamlessly from early safety testing (Phase I) to large-scale efficacy studies (Phase III). However real-world trials often face critical roadblocks that threaten their viability. In the worst case scenarios, a study might…

Rajhans SHARMA, PhD Business Developer Officer Rajhans is a Business Development Officer at ExperTrials, specializing in building strategic partnerships with Biotech and Medtech SMEs, guiding them through their clinical development needs. He holds a Master’s in Nanotechnology, PhD in Drug…

Meet Sandrine Kahi, Auditor and part of ExperTrials' leadership Team   Join us for an insightful interview with Sandrine Kahi, Auditor at ExperTrials, as she shares her expertise in clinical trial auditing. Discover her unique approach to ensuring quality and…

Meet Elzbieta Lech, our Poland-based Senior Clinical Project Manager   ExperTrials prides itself on its international team of clinical research experts. On our blog, you already had the chance to read about Aurélie Weiss-Guimet, our Contract Research Organization CEO and…

Would you like to learn more about ExperTrials? We have created a series of blog posts that are designed to let you know what our CRO is all about: its management style, its chosen size, and its market niche. In…

Glioblastoma is the most common malignant primary brain tumor in adults. Every year globally, more than 300,000 cases of glioblastoma are diagnosed (around 12,000 cases in the United States). The understanding of its biology has made considerable progress. However, therapeutic advances have…

Have you ever asked yourself how a small Contract Research Organization is run? We thought it would be worth explaining and decided it was a great opportunity to interview Aurélie Weiss-Guimet, our CEO and Founder (read her full portrait here). This…

Interview with Ghazala Kabani, Head of Clinical Operations in the U.S. at ExperTrials   ExperTrials is happy to welcome Ghazala Kabani into its team. She will act as Head of Clinical Operations in the United States as well as Senior…

ExperTrials was created in 2011 by Aurélie Weiss-Guimet (read her portrait here) and officially became a full-service CRO in 2019. The company’s core team includes eight members plus an operational team of 80 consultants across Europe with local expertise. It…

Interview with Pierre-Marie Gourmoud, a CRA turned Clinical Project Manager for our full-service CRO   This is the third interview of a series presenting ExperTrials’team. After ExperTrials’ CEO and Founder, Aurélie Weiss-Guimet, and Head of Clinical Operations Christoph Wachter, we…

A new Annex, Annex III, has been included in version 6.3 of the Q&A guidance relating to CTR No 536/2014.   The new CTR NO 536/2014 deadline will enter into force on January 31, 2023, as will the Questions &…

In 2019, ExperTrials was contacted by an American biotech to take over an ongoing rare diseases clinical trial in Europe.   In late 2019 a mid-size American biotech got in touch with ExperTrials about a multinational clinical trial regarding an…

Interview with Christoph Wachter, Head of Clinical Operations for our full-service CRO since 2020   Christoph Wachter has been Head of Clinical Operations and Clinical Project Manager at ExperTrials since September 2020. A dedicated professional with a long-standing experience in…

ExperTrials, the full-service Contract Research Organization founded by Aurélie Weiss-Guimet in 2011, celebrates its 12th birthday.   This month, October 2022, ExperTrials celebrated its 12th birthday! The full-service Contract Research Organization was founded by Aurélie Weiss-Guimet in October 2011. It…

Interview of Aurélie Weiss-Guimet,who founded ExperTrials, a full-service CRO, in 2011   Aurélie Weiss-Guimet started ExperTrials, a full-service Contract Research Organization, in 2011 in Lyon, France. Her CRO assists Biotech and Medtech companies doing clinical trials in Europe, guiding them…

The new CTR (Clinical Trial Regulation) No 536/2014 will repeal the existing Clinical Trial Directive No 2001/20CE on the 31st of January 2022. It’s impossible to summarize all changes that come along with this new regulation in one sentence, however

We are thrilled to announce that ExperTrials is the chosen CRO by Scynexis, Inc. for their phase II and by Vanda Pharmaceuticals, Inc. for a pivotal study (phase III).

Meet us on 14-18 June 2021 !

In an ideal clinical trial, investigational treatments run seamlessly from early safety testing (Phase I) to large-scale efficacy studies (Phase III). However real-world trials often face critical roadblocks that threaten their viability. In the worst case scenarios, a study might…

In 2019, ExperTrials was contacted by an American biotech to take over an ongoing rare diseases clinical trial in Europe.   In late 2019 a mid-size American biotech got in touch with ExperTrials about a multinational clinical trial regarding an…

Interview with Ghazala Kabani, Head of Clinical Operations in the U.S. at ExperTrials   ExperTrials is happy to welcome Ghazala Kabani into its team. She will act as Head of Clinical Operations in the United States as well as Senior…

ExperTrials, the full-service Contract Research Organization founded by Aurélie Weiss-Guimet in 2011, celebrates its 12th birthday.   This month, October 2022, ExperTrials celebrated its 12th birthday! The full-service Contract Research Organization was founded by Aurélie Weiss-Guimet in October 2011. It…

We are thrilled to announce that ExperTrials is the chosen CRO by Scynexis, Inc. for their phase II and by Vanda Pharmaceuticals, Inc. for a pivotal study (phase III).

Rajhans SHARMA, PhD Business Developer Officer Rajhans is a Business Development Officer at ExperTrials, specializing in building strategic partnerships with Biotech and Medtech SMEs, guiding them through their clinical development needs. He holds a Master’s in Nanotechnology, PhD in Drug…

Meet us on 14-18 June 2021 !

Meet Sandrine Kahi, Auditor and part of ExperTrials' leadership Team   Join us for an insightful interview with Sandrine Kahi, Auditor at ExperTrials, as she shares her expertise in clinical trial auditing. Discover her unique approach to ensuring quality and…

Meet Elzbieta Lech, our Poland-based Senior Clinical Project Manager   ExperTrials prides itself on its international team of clinical research experts. On our blog, you already had the chance to read about Aurélie Weiss-Guimet, our Contract Research Organization CEO and…

Interview with Ghazala Kabani, Head of Clinical Operations in the U.S. at ExperTrials   ExperTrials is happy to welcome Ghazala Kabani into its team. She will act as Head of Clinical Operations in the United States as well as Senior…

Interview with Pierre-Marie Gourmoud, a CRA turned Clinical Project Manager for our full-service CRO   This is the third interview of a series presenting ExperTrials’team. After ExperTrials’ CEO and Founder, Aurélie Weiss-Guimet, and Head of Clinical Operations Christoph Wachter, we…

Interview with Christoph Wachter, Head of Clinical Operations for our full-service CRO since 2020   Christoph Wachter has been Head of Clinical Operations and Clinical Project Manager at ExperTrials since September 2020. A dedicated professional with a long-standing experience in…

Interview of Aurélie Weiss-Guimet,who founded ExperTrials, a full-service CRO, in 2011   Aurélie Weiss-Guimet started ExperTrials, a full-service Contract Research Organization, in 2011 in Lyon, France. Her CRO assists Biotech and Medtech companies doing clinical trials in Europe, guiding them…

In honor of International Clinical Trials Day - a day dedicated to celebrating the vital contributions of clinical research professionals and organizations around the world - we sat down with our CRO’s CEO, Aurélie Weiss-Guimet, a clinical research professional with…

Would you like to learn more about ExperTrials? We have created a series of blog posts that are designed to let you know what our CRO is all about: its management style, its chosen size, and its market niche. In…

Glioblastoma is the most common malignant primary brain tumor in adults. Every year globally, more than 300,000 cases of glioblastoma are diagnosed (around 12,000 cases in the United States). The understanding of its biology has made considerable progress. However, therapeutic advances have…

Have you ever asked yourself how a small Contract Research Organization is run? We thought it would be worth explaining and decided it was a great opportunity to interview Aurélie Weiss-Guimet, our CEO and Founder (read her full portrait here). This…

ExperTrials was created in 2011 by Aurélie Weiss-Guimet (read her portrait here) and officially became a full-service CRO in 2019. The company’s core team includes eight members plus an operational team of 80 consultants across Europe with local expertise. It…

A new Annex, Annex III, has been included in version 6.3 of the Q&A guidance relating to CTR No 536/2014.   The new CTR NO 536/2014 deadline will enter into force on January 31, 2023, as will the Questions &…

The new CTR (Clinical Trial Regulation) No 536/2014 will repeal the existing Clinical Trial Directive No 2001/20CE on the 31st of January 2022. It’s impossible to summarize all changes that come along with this new regulation in one sentence, however